Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Diabetes

• Publication date

  2003-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2337/DIABETES.52.7.1825PMID 12829653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic heart disease

  2005cited by this paper
• Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts

  2003cited by this paper
• Cardiac excitation–contraction coupling

  2002cited by this paper
• Diabetes alter mRNA levels of calcium-release channels in human atrial appendage

  2002cited by this paper
• Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

  2002cited by this paper
• Downregulation of Myocardial Myocyte Enhancer Factor 2C and Myocyte Enhancer Factor 2C-Regulated Gene Expression in Diabetic Patients With Nonischemic Heart Failure

  2002cited by this paper
• Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats.

  2001cited by this paper
• The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts.

  2001cited by this paper
• Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts.

  2001cited by this paper
• Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links

  2001cited by this paper
• Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart.

  2001cited by this paper
• Protein glycation, diabetes, and aging.

  2001cited by this paper
• The effect of diabetes on expression of β1-, β2-, and β3-Adrenoreceptors in rat hearts

  2001cited by this paper
• Tectoridins modulate skeletal and cardiac muscle sarcoplasmic reticulum calcium-release channels.

  2000cited by this paper
• Diminished expression of sarcoplasmic reticulum Ca(2+)-ATPase and ryanodine sensitive Ca(2+)Channel mRNA in streptozotocin-induced diabetic rat heart.

  2000cited by this paper
• Role of oxidative stress in cardiovascular diseases

  2000cited by this paper
• Luminal loop of the ryanodine receptor: a pore-forming segment?

  1999cited by this paper
• Diabetic cardiomyopathy

  1998cited by this paper
• Altered Turnover of Calcium Regulatory Proteins of the Sarcoplasmic Reticulum in Aged Skeletal Muscle*

  1998cited by this paper
• Sequencing of two alternatively spliced mRNAs corresponding to the extracellular domain of the rat receptor for advanced glycosylation end products (RAGE).

  1998cited by this paper
• Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury

  1997cited by this paper
• Increased cardiovascular morbidity and mortality in diabetes mellitus: identification of the high risk patient.

  1996cited by this paper
• Diabetic Cardiomyopathy: A unique entity or a complication of coronary artery disease?

  1995cited by this paper
• Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding.

  1994cited by this paper
• Advanced glycosylation: chemistry, biology, and implications for diabetes and aging.

  1992cited by this paper
• Protein glycation and oxidative stress in diabetes mellitus and ageing.

  1991cited by this paper
• Diabetic Cardiomyopathy

  1990cited by this paper
• The Amadori product on protein: structure and reactions.

  1989cited by this paper
• Book ReviewText/Atlas of Histology Essentials of Human Embryology

  1988cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Diabetic heart disease.

  1980cited by this paper
• Diabetic cardiomyopathy.

  1974cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• New type of cardiomyopathy associated with diabetic glomerulosclerosis.

  1972cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Inhibition of the Renin–Angiotensin System Improves Hemodynamic Function of the Diabetic Rat Heart by Restoring Intracellular Calcium Regulation

  2025cites this paper
• Advanced Glycation End Products in Disease Development and Potential Interventions

  2025cites this paper
• The Role of Advanced Glycation End Products in the Etiology of Premature Ventricular Contractions.

  2025cites this paper
• Molecular Basis of Cardiomyopathies in Type 2 Diabetes

  2024cites this paper
• Glycation in the cardiomyocyte.

  2024cites this paper
• Subcutaneous advanced glycation end products, cardiovascular risk factors and vascular health during childhood development in a Swiss population

  2024cites this paper
• Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target

  2023cites this paper
• Advanced glycation end products are associated with cardiovascular risk in the Mexican population.

  2023cites this paper
• Ca2+ mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy

  2022cites this paper
• Advanced glycation end products via skin autofluorescence as a new biomarker for major adverse cardiovascular events: A meta-analysis of prospective studies.

  2022cites this paper
• Curcumin Prevents the Glycation of Tricarboxylic Acid Cycle and Cell Respiration Proteins in the Heart of Mice Fed with a High-Fructose Diet.

  2022cites this paper
• Aftermath of AGE-RAGE Cascade in the pathophysiology of cardiovascular ailments.

  2022cites this paper
• Effects of Obesity and Diabesity on Ventricular Muscle Structure and Function in the Zucker Rat

  2022cites this paper
• Diabetic cardiomyopathy: Clinical phenotype and practice

  2022cites this paper
• Acute Exposure to Glycated Proteins Impaired in the Endothelium-Dependent Aortic Relaxation: A Matter of Oxidative Stress

  2022cites this paper
• Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response

  2021cites this paper
• The association of coronary artery disease and advanced glycation end-products

  2021cites this paper
• AGE–RAGE Stress and Coronary Artery Disease

  2021cites this paper
• Clinical overview of diabetes mellitus as a risk factor for cardiovascular death.

  2021cites this paper
• Fructose Metabolism and Cardiac Metabolic Stress

  2021cites this paper
• Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions

  2021cites this paper
• Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy.

  2020cites this paper
• Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy

  2020cites this paper
• Calcium signaling in endocardial and epicardial ventricular myocytes from streptozotocin‐induced diabetic rats

  2020cites this paper
• Hypoglycemic Drugs and Advanced Glycation Endproducts

  2019cites this paper
• Role of AMPK in Diabetic Cardiovascular Complications: An Overview.

  2019cites this paper
• Ca

  2019cites this paper
• Food advanced glycation end products as potential endocrine disruptors: An emerging threat to contemporary and future generation.

  2019cites this paper
• Ryanodine Receptor Glycation Favors Mitochondrial Damage in the Senescent Heart

  2019cites this paper
• Left ventricular diastolic dysfunction in diabetes mellitus and the therapeutic role of exercise training

  2019cites this paper
• Impact of diabetes on cardiac and vascular disease: Role of calcium signaling.

  2019cites this paper
• Altered Intracellular Calcium Homeostasis and Arrhythmogenesis in the Aged Heart

  2019cites this paper
• From cell to heart: the impact of the cell organelles dysfunction on heart disease

  2018cites this paper
• Chlorogenic acid attenuates glucotoxicity in H9c2 cells via inhibition of glycation and PKC α upregulation and safeguarding innate antioxidant status.

  2018cites this paper
• Of mice and men: models and mechanisms of diabetic cardiomyopathy

  2018cites this paper
• Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats

  2018cites this paper
• Cardiac troponins may be irreversibly modified by glycation: novel potential mechanisms of cardiac performance modulation

  2018cites this paper
• Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity

  2018cites this paper
• The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review

  2018cites this paper
• Faculteit Geneeskunde en Levenswetenschappen School voor Levenswetenschappen master in de biomedische wetenschappen

  2018cites this paper
• DAF in diabetic patients is subject to glycation/inactivation at its active site residues☆

  2018cites this paper
• MG53 and disordered metabolism in striated muscle.

  2017cites this paper
• Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs

  2017cites this paper
• Myricitrin Alleviates Oxidative Stress-induced Inflammation and Apoptosis and Protects Mice against Diabetic Cardiomyopathy

  2017cites this paper
• 23 Insulin Resistance and Cardiomyopathy

  2017cites this paper
• Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.

  2017cites this paper
• Diabetic Cardiomyopathy and the Role of Regular Exercise in Preventing the Disease: A Review

  2017cites this paper
• Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?

  2016cites this paper
• Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.

  2016cites this paper
• An evaluation of trimetazidine as a therapeutic intervention in a newly established ex vivo mouse model of acute heart failure

  2016cites this paper
• Effect of streptozotocin-induced type I diabetes mellitus on the cardiac conduction system of the rat heart

  2016cites this paper
• Effects of insulin on peripheral nerves.

  2016cites this paper
• UPREGULATION OF RYANODINE RECEPTOR CALCIUM CHANNELS (RYR2) IN RATS WITH INDUCED DIABETES AFTER 4 WEEKS OF HIGH INTENSITY INTERVAL TRAINING

  2016cites this paper
• AGEing heart valves: a bittersweet stiffening process?

  2016cites this paper
• Assessment of left ventricular function in young type 1 diabetes mellitus patients by two-dimensional speckle tracking echocardiography: Relation to duration and control of diabetes

  2016cites this paper
• Diabetic Cardiomyopathy: The Case for a Role of Fructose in Disease Etiology

  2016cites this paper
• Physical activity and diabetic cardiomyopathy: myocardial adaptation depending on exercise load.

  2015cites this paper
• Glucose as an agent of post-translational modification in diabetes--New cardiac epigenetic insights.

  2015cites this paper
• Cardiovascular Consequences of Obesity and Type 2 Diabetes Damaging effects of hyperglycemia on cardiovascular function : spotlight on glucose metabolic pathways

  2015cites this paper
• Modulation of the Cardiac Calcium Release Channel by Homocysteine Thiolactone

  2014cites this paper
• Role of AGEs-RAGE system in cardiovascular disease.

  2014cites this paper
• Calcium-Handling Proteins in Diabetic Cardiomyopathy

  2014cites this paper
• The role of post‐translational modifications in acute and chronic cardiovascular disease

  2014influential citation
• Effects of Diabetes-Induced Hyperglycemia in the Heart: Biochemical and Structural Alterations

  2014cites this paper
• Elucidating the underlying mechanisms of benfotiamine-induced cardioprotection

  2014cites this paper
• Enzymatic and non-enzymatic post-translational modifications linking diabetes and heart disease

  2014cites this paper
• Pyridoxamine protects against mechanical defects in cardiac ageing in rats: studies on load dependence of myocardial relaxation

  2014cites this paper
• Basic Principles of Molecular Pathophysiology and Etiology of Cardiovascular Disorders

  2013cites this paper
• Pathophysiology-based novel pharmacotherapy for heart failure with preserved ejection fraction.

  2013cites this paper
• Protein glycation during aging and in cardiovascular disease.

  2013cites this paper
• Predictors and prevention of diabetic cardiomyopathy

  2013cites this paper
• Diabetes and Cardiac Mitochondria

  2013cites this paper
• Função cardíaca em cães com Diabetes Mellitus

  2013cites this paper
• FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival.

  2013cites this paper
• Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats

  2013cites this paper
• FoxO 1 is crucial for sustaining cardiomyocyte metabolism and cell survival

  2013cites this paper
• Advanced glycation end products: role in pathology of diabetic cardiomyopathy

  2013cites this paper
• CARBONYLATION INDUCES HETEROGENEITY IN CARDIAC RYANODINE RECEPTORS (RyR2) FUNCTION DURING DIABETES

  2012cites this paper
• Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?

  2012cites this paper
• Combined insulin treatment and intense exercise training improved basal cardiac function and Ca(2+)-cycling proteins expression in type 1 diabetic rats.

  2012cites this paper
• Carbonylation Induces Heterogeneity in Cardiac Ryanodine Receptor Function in Diabetes Mellitus

  2012cites this paper
• Insulin Resistance and Cardiomyopathy

  2012cites this paper
• The role of inflammation in diabetic cardiomyopathy

  2012cites this paper
• Influência do Antioxidante Quercetina sobre a Remodelação Cardíaca e a Atividade Oxidativa de Ratos com Diabetes Mellitus

  2012cites this paper
• Early cardiac effects of a high-sucrose diet in a rat model of prediabetes

  2012cites this paper
• Novel mechanistic insights into the role of advanced glycation end products in the development of diabetic cardiomyopathy

  2012influential citation
• Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling

  2012cites this paper
• Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia.

  2012cites this paper
• Role of advanced glycation end products in cardiovascular disease.

  2012cites this paper
• The link between iron, metabolic syndrome, and Alzheimer’s disease

  2011cites this paper
• AVALIAÇÃO DOPPLERECOCARDIOGRÁFICA DA FUNÇÃO DIASTÓLICA DO VENTRÍCULO ESQUERDO EM CRIANÇAS E ADOLESCENTES PORTADORES DE DIABETES TIPO 1

  2011cites this paper
• Swimming training attenuates contractile dysfunction in diabetic rat cardiomyocytes.

  2011cites this paper
• Nature of fatty acids in high fat diets differentially delineates obesity-linked metabolic syndrome components in male and female C57BL/6J mice

  2011cites this paper
• Diabetic cardiomyopathy and post-infarct ventricular remodelling Effects of levosimendan in a rodent model of type II diabetes

  2011cites this paper
• Chapter 26 – Heart Failure as a Consequence of Diabetic Cardiomyopathy

  2011cites this paper
• Ryanodine Receptor: A New Therapeutic Target to Control Diabetic Cardiomyopathy

  2011cites this paper
• Endoplasmic-reticulum calcium depletion and disease.

  2011cites this paper
• Signaling in Diabetes and Metabolic Syndrome

  2011cites this paper
• Diabetic cardiomyopathy and post-infarct ventricular remodelling : Effects of levosimendan in a rodent model of type II diabetes

  2011cites this paper
• Advanced glycation end products and diabetic retinopathy

  2011influential citation